Micro-pollutants in Hospital Effluent: Their Fate, Risk and Treatment Options

Handbook of Environmental Chemistry

Volumn 20, Issue , 2012, Pages 139-171

  Verlicchi, Paola ^a   Galletti, Alessio ^a   Petrovic, Mira ^b,c   Barceló, Damià ^b,d,e  

^a UNIVERSITY OF FERRARA   (Italy)

^b CATALAN INSTITUTE FOR WATER RESEARCH ICRA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Environmental risk assessment; Hospital effluents; Management and treatment; Pharmaceuticals

Indexed keywords

EID: 84884183419     PISSN: 1867979X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/698_2011_134     Document Type: Chapter

References (124)

1. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36:1202-1211
2. Foster AL (2007) Occurrence and fate of endocrine disruptors through the San Marco Wastewater treatment plant. Thesis of Master of Science, Texas State University, USA
3. Fatta-Kassinos D, Meric S, Nikolaou A (2011) Pharmaceutical residues in environmental waters and wastewater: current status of knowledge and future research. Anal Bioanal Chem 399:251-275
4. Khan S, Ongerth J (2005) Occurrence and removal of pharmaceuticals at an Australian sewage treatment plant. Water 32:35-39
5. Joss A, Andersen H, Ternes T, Richle PR, Siegrist H (2004) Removal of estrogen in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ Sci Technol 38:3047-3055
6. Joss A, Keller E, Alder AC, Gobel A, McArdell CS, Ternes T, Siegrist H (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39:3139-3152
7. Duong H, Pham N, Nguyen H, Hoang T, Pham H, Ca Pham V, Berg M, Giger W, Alder A (2008) Occurrence, fate and antibiotic resistance of fluoroquinolone antibacterials in hospital wastewaters in Hanoi, Vietnam. Chemosphere 72:968-973
8. Suarez S, Lema JM, Omil F (2009) Pre-treatment of hospital wastewater by coagulation-flocculation and flotation. Bioresour Technol 100:2138-2146
9. Verlicchi P, Galletti A, Petrovic M, Barcelò D (2010) Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J Hydrol 389:416-428
10. Sim WJ, Lee JW, Lee ES, Shin SK, Hwang SR, Oh JE (2011) Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 82:179-186
11. Hawkshead JJ (2008) Hospital wastewater containing pharmaceuticals active compounds and drug-resistant organisms: a source of environmental toxicity and increased antibiotic resistance. J Residual Sci Tech 5:51-60
12. Pauwels B, Verstraete W (2006) The treatment of hospital wastewater: an appraisal. J Water Health 4:405-416
13. Verlicchi P, Galletti A, Masotti L (2010) Management of hospital wastewaters: the case of the effluent of a large hospital situated in a small town. Water Sci Technol 61:2507-2519
14. Schuster A, Hadrick C, Kummerer K (2008) Flows of active pharmaceutical ingredients originating from health care practises on a local, regional, and national level in Germany -is hospital effluent treatment an effective approach for risk reduction? Water Air Soil Pollut Focus 8:457-471
15. Leprat P (1999) Caractéristiques et impacts des rejets liquides hospitaliers. Tech Hosp 634:56-57
16. Altin A, Altin S, Degirmenci M (2003) Characteristics and treatability of hospital (medical) wastewaters. Fresenius Environ Bull 12:1098-1108
17. Kummerer K, Erbe T, Gartiser S, Brinker L (1998) AOX-emissions from hospital into municipal wastewater. Chemosphere 36:2437-2445
18. Wen X, Ding H, Huang X, Liu R (2004) Treatment of hospital wastewater using a submerged membrane bioreactor. Process Biochem 39:1427-1431
19. Emmanuel E, Perrodin Y, Keck G, Blanchard JM, Vermande P (2005) Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network. J Hazard Mater A117:1-11
20. Emmanuel E, Pierre MG, Perrodin Y (2009) Groundwater contamination by microbiological and chemical substances released from hospital wastewater: health risk assessment for drinking water consumers. Environ Int 35:718-726
21. Hartemann P, Hautemaniere A, Joyeux M (2005) La problématique des effluents hospitaliers. Hygiène 13:369-374
22. Tsakoma M, Anagnostopoulou E, Gidarakos E (2007) Hospital waste management and toxicity evaluation: a case study. Waste Manag 27:912-920
23. Boillot C, Bazin C, Tissot-Guerraz F, Droguet J, Perraud M, Cetre JC, Trepo D, Perrodin Y (2008) Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. Sci Total Environ 403:113-129
24. Verlicchi P, Galletti A, Al Aukidy M (2011) Hospital wastewaters: quali-quantitative characterization and strategies for their treatment and disposal. In: Sharma SK, Sanghi R (eds) Water treatment and pollution prevention: advances in research. Springer (in press)
25. Lopez N, Deblonde T, Hartemann Ph (2010) Les effluents liquid hospitaliers. Hygiène 18:405-410
26. Gomez MJ, Aguera A, Mezcua M, Hurtado J, Mocholi F, Fernandez-Alba AR (2007) Simultaneous analysis of neutral and acidic pharmaceuticals as well as related compounds by gas chromatography-tandem mass spectrometry in wastewater. Talanta 73:314-320
27. Kummerer K, Henninger A (2003) Promoting resistance by the emission of antibiotics from hospital and households into effluent. Clin Microbiol Infect 9:1203-1214
28. Schwartz T, Kohnen W, Jansen B, Obst U (2003) Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and water biofilms. FEMS Microbiol Ecol 43:325-335
29. Adelowo O, Fagade OE, Oke AJ (2008) Prevalence of co-resistance to disinfectants and clinically relevant antibiotics in bacterial isolates from three hospital laboratory wastewaters in South-western Nigeria. World J Microbiol Biotechnol 24:1993-1997
30. Chitnis V, Chitnis S, Vaidya K, Ravikant S, Patil S, Chitnis DS (2004) Bacterial population changes in hospital effluent treatment plant in central India. Water Res 38:441-447
31. Prado T, Silva DM, Guilayn WC, Rose TL, Gaspar AMC, Miagostovich MP (2011) Quantification and molecular characterization of enteric viruses detected in effluents from two hospital wastewater treatment plants. Water Res 45:1287-1297
32. Kummerer K (2001) Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospital in relation to other sources -a review. Chemosphere 45:957-969
33. Kummerer K, Helmers E, Hubner P, Mascart G, Milandri M, Reinthaler F, Zwakenberg M (1999) European hospitals as a source for platinum in the environment in comparison with other sources. Sci Total Environ 225:155-165
34. Lenz K, Mahnik SN, Weissenbacher N, Mader RM, Krenn P, Hann S, Koellensperger G, Uhl M, Knasmuller S, Ferk F, Bursch W, Fuerhacker M (2007) Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater. Water Sci Technol 56:141-149
35. Kummerer K, Helmers E (2000) Hospital effluents as a source of gadolinium in the aquatic environment. Environ Sci Technol 34:573-577
36. Verlicchi P, Galletti A, Masotti L (2008) Caratterizzazione e trattabilità di reflui ospedalieri: in-dagine sperimentale (con sistemi MBR) presso un ospedale dell’area ferrarese, Proc. Sidisa Conference Florence, Italy
37. Barceló D (2003) Emerging pollutants in water analysis. Trac-Trend Anal Chem 22:14-16
38. Jjemba PK (2006) Excretion and ecotoxicity of pharmaceuticals and personal care products in the environment. Ecotox Environ Safe 63:113-130
39. Halling-Sorensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lutzhoft HC, Jorgensen SE (1998) Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36:357-393
40. Lienert J, Burki T, Escher BI (2007) Reducing micropollutants with source control: substance flow analysis of 212 pharmaceuticals in faeces and urine. Water Sci Technol 55:87-96
41. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5-17
42. Verlicchi P, Al Aukidy M, Galletti A, Petrovic M, Barcelò D (2011) Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment (in press)
43. Lin AYC, Yu TH, Lin CF (2008) Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan. Chemosphere 74:131-141
44. Galletti A, Verlicchi P, Al Aukidy M, Petrovic M, Barcelò D (2011) Hospital as a source of emerging contaminants (pharmaceuticals): results of an investigation on its final effluent chemical characteristics. Proc. CEST 2011, Rhodes A578-A587
45. Tauxe-Wuersch A, De Alencastro LP, Grandjean D, Tarradellas J (2006) Trace determination of tamoxifen and 5-fluorouracil in hospital and urban wastewaters. Int J Environ Anal Chem 86:473-485
46. Gomez MJ, Petrovic M, Fernandez-Alba AR, Barcelò D (2006) Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters. J Chromatogr A 1114:224-233
47. Nagarnaik P, Batt A, Boulanger B (2011) Source characterization of nervous active pharmaceutical ingredients in healthcare facility wastewaters. J Environ Manage 92:872-877
48. Heberer T, Feldman D (2005) Contribution of effluents from hospital and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents -modeling versus measurements. J Hazard Mater 122:211-218
49. Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS (2011) Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 45:75-92
50. EMEA (2003) Note for guidance on environmental risk assessment of medicinal products for human use. DRAFT. CPMP/SWP/4447/00 draft corr. The European Agency for the Evaluation of Medical Products
51. EMEA (2006) Guideline on the environmental risk assessment of medicinal products for human use CHMP/SWP/4447/00. The European Agency for the Evaluation of Medicinal Products, London
52. DDD data web site URL: http://www.whocc.no/atc_ddd_index/. Accessed 2 Nov 2011
53. Kummerer K (2009) Antibiotics in the aquatic environment -a review -Part I. Chemosphere 75:417-439
54. Epi: suite program available at the website (accessed 28 Oct 2011) http://www.epa.gov/oppt/exposure/pubs/episuite.htm
55. Suarez S, Carballa M, Omil F, Lema JM (2008) How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters? Rev Environ Sci Biotechnol 7:125-138
56. Ternes TA, Joss A (2006) Human Pharmaceuticals, Hormones and Fragrances. The challenge of micropollutants in urban water management. IWA Publishing, London
57. Joss A, Zabczynsk S, Gobel A, Hoffmann B, Loffler D, McArdell CS, Ternes TA, Thomsen A, Siegrist H (2006) Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 40:1686-1696
58. Radjenovic J, Petrovic M, Barceló D (2009) Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 43:831-841
59. Clara M, Kreuzinger N, Strenn B, Gans O, Kroiss H (2005) The solids retention time—a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 39:97-106
60. USEPA (2009) Nutrient Control Design Manual, State of Technology Review report, EPA/600/R-09/012, U.S. Environmental Protection Agency, Washington, D.C.
61. Kummerer K (2009) The presence of pharmaceuticals in the environment due to human use -present knowledge and future challenges. J Environ Manage 90:2354-2366
62. Golet EM, Alder AC, Giger W (2002) Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. Environ Sci Technol 36:3645-3651
63. Gu C, Karthikeyan KG (2005) Sorption of the antimicrobial ciprofloxacin to aluminum and iron hydrous oxides. Environ Sci Technol 39:9166-9173
64. Christian T, Schneider RJ, Färber HA, Skutlarek D, Meyer MT, Goldbach HE (2003) Determination of antibiotic residues in manure, soil, and surface waters. Acta Hydrochim Hydrobiol 31:36-44
65. Gu C, Karthikeyan KG (2008) Sorption of the antibiotic tetracycline to humic-mineral complexes. J Environ Qual 37:704-711
66. Carballa M, Omil F, Lema JM (2005) Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res 39:4790-4796
67. Bendz D, Paxéus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active in the environment, a case study: Hoje River in Sweden. J Hazard Mater 122:195-204
68. Vieno N, Tuhkanen T, Kronberg L (2007) Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 41:1001-1012
69. Jalonen HG (1988) Simultaneous determination of tamoxifen citrate and its E-isomer impurity in bulk drug and tablets by high-performance liquid-chromatography. J Pharm Sci 77:810-813
70. Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319-1330
71. Werner JJ, Arnold WA, McNeill K (2006) Water hardness as a photochemical parameter: tetracycline photolysis as a function of calcium concentration, magnesium concentration, and pH. Environ Sci Technol 40:7236-7241
72. Kallenborn R, Fick J, Lindberg R, Moe M, Nielsen KM, Tysklind M, Vasskog T (2008) Pharmaceutical residues in Northern European environments: consequences and perspectives. In: Kümmerer K (ed) Pharmaceuticals in the environment. Sources, fate, effects and risk, 3rd edn. Springer, Berlin, pp 61-74
73. Turiel E, Bordin G, Rodríguez AR (2005) Study of the evolution and degradation products of ciprofloxacin and oxolinic acid in river water samples by HPLC-UV/MS/MS-MS. J Environ Monit 7:189-195
74. Hu L, Flanders PM, Miller PL, Strathmann TJ (2008) Oxidation of sulfamethoxazole and related antimicrobial agents by TiO2 photocatalysis. Water Res 41:2612-2626
75. Sukul P, Lamshöft M, Zühlke S, Spiteller M (2008) Photolysis of (14)C-sulfadiazine in water and manure. Chemosphere 71:717-725
76. Verlicchi P, Galletti A, Al Aukidy M (2011) Best practices in the management of hospital effluents. Proc. VI EWRA International Symposium Water Engineering and Management in a Changing Environment, Catania, Italy
77. Kreuzinger N, Clara M, Droiss H (2004) Relevance of the Sludge Retention Time (SRT) as de-sign criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci Technol 50:149-156
78. Kimura K, Hara H, Watanabe Y (2007) Elimination of selected acidic pharmaceuticals from municipal wastewaters by activated sludge systems and membrane bioreactors. Environ Sci Technol 41:3708-3714
79. Oppenheimer J, Wert EC, Yoon Y (2007) Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202:156-181
80. Radjenovic J, Petrovic M, Barceló D (2007) Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387:1365-1377
81. Ottoson J, Hansen A, Bjorlenius B, Norder H, Stenstrom TA (2006) Removal of viruses, parasitic protozoa and microbial indicators in conventional and membrane processes in a wastewater pilot plant. Water Res 40:1449-1457
82. Zhang K, Farahbakhsh K (2007) Removal of native coliphages and coliform bacteria from municipal wastewater by various wastewater treatment processes: implications to water reuse. Water Res 41:2816-2824
83. Batt AL, Kim S, Aga DS (2007) Comparison of the occurrence of antibiotics in four-full scale wastewater treatment plants with varying designs and operations. Chemosphere 68:428-435
84. Ikehata K, Naghashkar NJ, El-Din MG (2006) Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone-Sci Eng 28:353-414
85. Bolong N, Ismail AF, Salim MR, Matsuura T (2009) A review of the effects of emerging contaminants in wastewaters and options for their removal. Desalination 239:229-246
86. Snyder SA, Adham S, Redding AM, Cannon FS, DeCarolis J, Oppenheimer J, Wert EC, Yoon Y (2006) Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202:156-181
87. Watkinson AJ, Murby EJ, Costanzo SD (2007) Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling. Water Res 41:4164-4174
88. Emmanuel E, Keck G, Blanchard J, Vermande P, Perrodin Y (2004) Toxicological effects of disinfections using sodium hypochlorite on aquatic organisms and its contribution to AOX formation in hospital wastewater. Environ Int 30:891-900
89. Galletti A, Al Aukidy M, Verlicchi P, Petrovic M, Barcelò D (2010) Pharmaceuticals removal in a H-SSF treating a secondary domestic wastewater -an experimental investigation. Proc. IWA Conference Wetland Systems for Water Pollution Control, Venice, 382-384
90. Matamoros V, Garcia J, Bajona JM (2008) Organic micropollutant removal in a full-scale surface flow constructed wetland fed with secondary effluent. Water Res 42:653-660
91. Bartels P, von Tumpling W (2008) The environmental fate of the antiviral drug oseltamivir carboxylate in different waters. Sci Total Environ 405:215-225
92. Beier S, Cramer C, Koster S, Mauer C, Palmowski L, Schroeder HF, Pinnekamp J (2011) Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. Water Sci Technol 63:66-71
93. Beier S, Koster S, Veltmann K, Schroder HFr, Pinnekamp J (2010) Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis. Water Sci Technol 61:1691-1698
94. Liu Q, Zhou Y, Chen L, Zheng X (2010) Application of MBR for hospital wastewater treatment in China. Desalination 250:605-608
95. Bound JP, Voulvoulis N (2006) Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment. Water Res 40:2585-2592
96. Furhacker M (2008) The Water Framework Directive -can we reach the target? Water Sci Technol 57:9-17
97. Council Directive 93/39/EEC 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products
98. EMEA (2001) Discussion paper on environmental risk assessment on non-genetically modified organisms (non-GMO) containing medicinal products for human use. CPMP/SWP/4447/00 draft corr. The European Agency for the Evaluation of Medical Products
99. Lienert J, Gudel K, Escher BI (2007) Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ Sci Technol 41:4471-4478
100. Brown VM (1968) The calculation of the acute toxicity of mixture of poisons to rainbow trout. Water Res 2:723-733
101. Altenburger R, Nendza M, Schuurmann G (2003) Mixture toxicity and its modeling by quantitative structure-activity relationships. Environ Toxicol Chem 22:1900-1915
102. Altenburger R, Walter H, Grote M (2004) What contributes to the combined effect of a complex mixture? Environ Sci Technol 38:6353-6362
103. Hernando MD, Mezcua M, Fernandez-Alba AR, Barceló D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69:334-342
104. de Souza SML, de Vasconcelos EC, Dziedzic M (2009) Environmental risk assessment of antibiotics: an intensive care unit analysis. Chemosphere 77:962-967
105. Zhao JL, Ying GG, Liu YS, Chen F, Yang JF, Wang L, Yang XB, Stauber JL, Warne MSt J (2010) Occurrence and screening level risk assessment of human pharmaceutical in the Pearl River system, South China. Environ Toxicol Chem 29:1377-1384
106. Tauxe-Wuersch A, De Alencastro LF, Grandjean D, Tarradellas J (2005) Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 39:1761-1772
107. EC (2003) Technical guidance on risk assessment, TGD Part II. Technical Report, Institute for health and consumer protection, European Chemicals Bureau, European Commission (EC)
108. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, Daphnia and algae by ECOSAR screening. Toxicol Lett 144:383-395
109. Stuer-Lauridsen F, Birkved M, Hansen LP, Holten Lutzhoft H-C, Halling-Sùrensen B (2000) Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40:783-793
110. Boillot C (2008) Évaluation des risques écotoxicologiques liés aux rejets d’effluents hospitaliers dans les milieux aquatiques. Contribution à l’amélioration de la phase « caractérisation des effets ». PhD Thesis. Institut National des Sciences Appliquées de Lyon, France, N° d’ordre ISAL 0021
111. Ferrari B, Paxeus N, Lo Giudice R, Pollio A, Garric J (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotox Environ Safe 55:359-370
112. Escher BI, Baumgartner R, Lienert J, Fenner K (2009) In: Boxall ABA (ed) Reaction and processes, Part P -transformation products of synthetic chemicals in the environment, vol 2. Springer, Berlin, pp 205-244. doi: 10.1007/1978-1003-1540-88273-88272
113. Santos JL, Aparicio I, Alonso E (2007) Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 33:596-601
114. Santos LHMLM, Araujo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175:45-95
115. Chitnis V, Chitnis D, Patil S, Kant R (2000) Hospital effluent as a source of multiple drug-resistant bacteria. Curr Sci India 79:989-991
116. Kummerer K (2004) Resistance in the environment. J Antimicrob Chemother 54:311-320
117. Jolibois B, Guerbet M (2005) Evaluation of industrial, hospital and domestic wastewater genotoxicity with the Salmonella fluctuation test and the SOS chromotest. Mutat Res 565(2):151-162
118. Ferk F, Misik M, Grummt T, Majer B, Fuerhacker M, Buchmann C, Vital M, Uhl M, Lenz K, Grillitsch B, Parzefall W, Nersesyan A, Knasmuller S (2009) Genotoxic effects of wastewater from an oncological ward. Mutat Res 672:69-75
119. Hirsch R, Ternes TA, Haberer K, Kratz KL (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109-118
120. Al-Almad A, Daschner FD, Kummerer K (1999) Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G and sulfamethoxazole and inhibition of wastewater bacteria. Arch Environ Contam Toxicol 37:158-163
121. Clara M, Strenn B, Kreuzinger N (2004) Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res 38:947-954
122. Blaise C, Gagné F, Eulaffroy P, Férard J-F (2007) Ecotoxicology of selected pharmaceuticals of urban origin discharged to the Saint-Lauwence river (Québec, Canada): a review. Braz J Aquat Sci Technol 10:29-51
123. Berto J, Rochenbach GC, Barreiros MAA, Correa AXR, Silva SP, Radetski CM (2009) Physico-chemical microbiological and ecotoxicological evaluation of a septic tank/Fenton reaction combination for the treatment of hospital wastewaters. Ecotox Environ Safe 72:1076-1081
124. Hollender J, Zimmermann SG, Koepke S, Krauss M, McArdell CS, Ort C, Singer H, von Gunten U, Siegrist H (2009) Elimination of organic micropollutants in a municipal wastewater treatment plant Upgraded with a full-scale Post ozonation followed by sand filtration. Environ Sci Technol 43:7862-7869